TauC3 Biologics Limited and LifeArc Announce their Selection by the Program Committee to Present at Tau2020 during the Lightning Round Poster Presentation WASHINGTON and LONDON, Feb. 11, 2020 (GLOBE NEWSWIRE) -- TauC3 Biologics Limited and Life Arc have been selected by the Tau2020 Global Conference Program Committee to present at Tau2020, being held...

TauC3 Biologics Limited Announces the Appointments of Industry Leaders Andrew Heath MD, PhD and Shafique Virani, MD as Non-Executive Chairman and Director, respectively. LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) -- TauC3 Biologics Limited, a newly established privately held British biopharmaceutical company developing an innovative immunotherapy with the demonstrated...